Spots Global Cancer Trial Database for A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19
Official Title: Single-center, Phase II, Randomized Double-blind, Placebo-controlled Study of Hydroxychloroquine Compared to Placebo as Treatment for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Study ID: NCT04379492
Study Description
Brief Summary: This study is being done to see if hydroxychloroquine is an effective treatment for COVID-19.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Memorial Sloan - Kettering Cancer Center, New York, New York, United States
Contact Details
Name: Genovefa Papanicolaou, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
